The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
- 1 July 1983
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 106 (1) , 29-34
- https://doi.org/10.1016/0002-8703(83)90434-9
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Biochemical measurements of endomyocardial biopsiesCatheterization and Cardiovascular Diagnosis, 1981
- Long-term benefit of dobutamine in patients with congestive cardiomyopathyAmerican Heart Journal, 1980
- Techniques for right and left ventricular endomyocardial biopsyThe American Journal of Cardiology, 1978
- Interaction between the creatine kinase of heart mitochondria and oxidative phosphorylationJournal of Molecular and Cellular Cardiology, 1977
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977
- Hemodynamic effect of dobutamine in patients with severe heart failureThe American Journal of Cardiology, 1975
- Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure.Heart, 1975
- Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.Circulation Research, 1975
- Measurement of blood flow by thermodilutionThe American Journal of Cardiology, 1972
- Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in ManCirculation, 1971